Drug profile · INN
triple sulfa (sulfabenzamide
VAGILIA
triple sulfa (sulfabenzamide (VAGILIA) is a unknown. Route of administration: vaginal. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — triple sulfa (sulfabenzamide
- US status
- approved
- Class
- —
- Route
- VAGINAL
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
triple sulfa (sulfabenzamide (VAGILIA) is a unknown. Route of administration: vaginal. Current US regulatory status: approved.
Key facts
INN triple sulfa (sulfabenzamide
Brand VAGILIA
Mechanism Unknown
Route VAGINAL
Formulation TABLET
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is triple sulfa (sulfabenzamide?
triple sulfa (sulfabenzamide (VAGILIA) is a unknown. Route of administration: vaginal. Current US regulatory status: approved.
What is the brand name for triple sulfa (sulfabenzamide?
VAGILIA is a marketed brand name for triple sulfa (sulfabenzamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of triple sulfa (sulfabenzamide?
triple sulfa (sulfabenzamide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.